NFE2L2 and Parkinson disease: Therefore, a dual modulator of GSK-3β inhibitor/Nrf2 inducers of fumarate and curcumin-based analog (Figure 1h) has been designed, and it has exhibited significant neuroprotective effects to PD therapeutics [73].